By: Dinesh Nair, Michelle F Davis
Johnson & Johnson is exploring a bid to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said.
Dinesh Nair is the Chief Correspondent at Global Deals. He specializes in finance, investment, trading, and the banking sector, with a keen focus on markets, private equity, and the financial services industry, particularly in the UAE and biotech sectors. Dinesh's work has been featured in notable publications such as Moneyweb, Bloomberg Law, and The Sydney Morning Herald, among others.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Dinesh Nair's coverage primarily focuses on mergers and acquisitions, investment, financial deals, and business news across various industries such as healthcare & pharmaceuticals, energy, and real estate. He frequently covers private sector announcements and press releases.
Given the nature of his articles, Dinesh would likely be interested in pitches related to exclusive information about potential mergers or acquisitions within the mentioned industries or insider insights into major financial deals. Additionally, he may also be open to receiving pitches regarding significant appointments or changes within companies that could impact their market position.
Dinesh doesn't specify a geographic focus but given the international scope of M&A activity covered in his articles, he is likely interested in global developments rather than those limited to specific regions.
This information evolves through artificial intelligence and human feedback. Improve this profile .